IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
Recruiting · NCT06513429 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE) | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Not applicable | 2026-08-31 | NCT06513429 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University Third Hospital | 243 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Universitiy Third Hospital | Beijing | China | 1 |